Krystal Biotech, Inc. (KRYS) vs Vaxcyte, Inc. (PCVX)
- Krystal Biotech, Inc. KRYS 316.58 −4.07%
- Vaxcyte, Inc. PCVX 63.62 −2.53%
Krystal Biotech, Inc. and Vaxcyte, Inc. are both Biotechnology companies. Krystal Biotech, Inc. and Vaxcyte, Inc. are of similar size ($10.3B and $9.8B). Vaxcyte, Inc. has negative trailing earnings, so its P/E is not meaningful; Krystal Biotech, Inc. trades at 38.3×. Krystal Biotech, Inc. has the higher net margin (54.8% vs 0.00%) and the higher return on invested capital (24.1% vs −57.3%). Across the 13 metrics below, Krystal Biotech, Inc. leads on 12 and Vaxcyte, Inc. on 1.
Valuation
Profitability
| Metric | KRYS | PCVX | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.64% | 0.00% | 65.16% |
| Operating margin | 44.89% | 0.00% | 0.00% |
| Net margin | 54.82% | 0.00% | 0.00% |
| Free cash flow margin | 58.52% | 0.00% | 0.00% |
| Return on equity | 20.12% | (36.51%) | (56.36%) |
| Return on assets | 18.30% | (33.03%) | (48.04%) |
| Return on invested capital | 24.07% | (57.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack